This program evaluated the efficacy and safety of oral semaglutide in patients with DM2 from monotherapy to insulin addition, including HbA1c and body weight reduction outcomes, in addition to other relevant efficacy and safety endpoints, as compared to both placebo and other common antihyperglycemic drugs
Article: What is Liposomal Glutathione
Comparison of biochemical indicators At 12 and 20 weeks of treatment, the semaglutide-intensified treatment group demonstrated significant reductions in fasting plasma glucose, fasting insulin, and HOMA-IR compared to the standard treatment group, with significant differences ( P 0.05) [Table 1]
Better for Those with Limited Mobility or Dexterity Some individuals have limited mobility or dexterity, which makes handling needles difficult
Balance blood sugar and reduce cravings Address emotional and stress-related eating or refer to someone who can help if needed Create sustainable eating habits Tackle root causes like inflammation or hormonal imbalances Final Thoughts GLP-1s can be a powerful toolbut theyre just one piece of the puzzle